Navigation Links
Nephros Reports 2010 First Quarter Financial Results
Date:5/13/2010

hros HDF system removes a range of harmful substances more effectively, and with greater capacity, than existing ESRD treatment methods, particularly with respect to substances known collectively as "middle molecules." These molecules have been found to contribute to such conditions as dialysis-related amyloidosis, carpal tunnel syndrome, degenerative bone disease and, ultimately, mortality in the ESRD patient. Nephros ESRD products are sold and distributed throughout Europe and are currently being used in over fifty clinics in Europe.

The Nephros Dual Stage Ultrafilter (DSU) is the basis for the Nephros line of water filtration products. The patented dual stage cold sterilization ultrafilter has the capability to filter out bacteria and, due to its exceptional filtration levels, filter out many viruses, parasites and biotoxins. Nephros's DSUs are being evaluated at several major U.S. medical centers for infection control. The DSU has also been selected for further development by the U.S. Marine Corps for purification of drinking water by soldiers in the field.

For more information about Nephros, please visit our website at http://www.nephros.com  

Forward-Looking Statements

Statements in this news release that are not historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Such statements may be preceded by words such as "may," "plans," "expects," "believes," "hopes," "potential" or similar words. For such statements, Nephros claims the protection of the PSLRA.'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nephros Signs Development Agreement with STERIS
2. Nephros Signs Canadian Distribution Agreement with Bellco Health Care Inc.
3. Nephros Reports 2009 Third Quarter Financial Results
4. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
5. DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
6. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
7. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
8. Fake Pharmacy Licenses, No-Prescription Meds OK with Internet Companies, LegitScript Reports
9. Stimatix GI Reports Encouraging Interim Results
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Repligen Reports Notice of Allowance of a United States Patent Covering the Use of Uridine to Treat the Symptoms of Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 RadiologyAuction will have their ... video and product demonstrations at the end of the ... such as Kodak and Fuji Cr,s, Agfa and Sony, ... the first event. Various imaging equipment will be available ... After years of buying and selling imaging ...
(Date:5/4/2015)... May 4, 2015  Oncobiologics, Inc., a biotherapeutics ... (mAb) biosimilars, has completed the construction of its ... in Cranbury, New Jersey . ... facility is designed to utilize multiple technologies that ... scale.  Through the use of the latest single-use ...
(Date:5/4/2015)... Calif. , May 4, 2015  Isis Pharmaceuticals, ... exclusive license agreement with Bayer HealthCare (Bayer) to develop ... thrombosis. Under the terms of the agreement, Isis is ... payments, including an immediate $100 million up-front payment and ... following a Phase 2 study in patients with compromised ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
(Date:5/4/2015)... Each year, the Susan G. Komen organization ... awareness for breast cancer. This year, Dr. Mark Deutsch and ... the entertainment sponsor for the 25th annual Susan G. Komen ... the Lenox Square Mall. , The Komen organization hopes have ... $1.2 million. Perimeter Plastic Surgery has not only taken on ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Getting patients ... manage their health is critical to achieving the “triple ... reducing costs, but this will require a shift in ... also demands that health systems move beyond their traditional ... took part in the third live meeting of the ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 “ LiveSchool ... monthly AppWatch, which takes a look at the latest ... and Windows. Joe Toohey, the host of AppWatch and ... viewers how this application allows teachers to reward students ... than some realize, especially in the classroom. And ...
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – the ... lymphoma research and serving the lymphoma community through a ... services – is set to host its annual Ace ... Orange, NJ on June 1, 2015. Since 2010, the ... through LRF. , This year, the Lymphoma Research Foundation ...
(Date:5/4/2015)... The opportunity for children to dream of ... motivating forces behind The Fairy Godmother Next Door, a new ... L. Stark. , The inspiration for the enchanting story of ... from Stark’s desire to be a fairy godmother. , “My ... to my neighbors’ children since they were born. We discuss ...
Breaking Medicine News(10 mins):Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2
... 8, 2007 -- Results from two investigational Phase I ... preliminary anti-tumor activity in patients with relapsed and/or refractory ... 10 of 21 (48 percent) evaluable patients had a ... combination treatment. Data from a second study, sponsored ...
... Boca Raton, FL, December 8, 2007 Researchers may ... almost immediately by directly targeting novel molecules in the ... can lead to longer times for medication to take ... American College of Neuropsychopharmacology (ACNP) annual meeting. The antidepressant ...
... Elderly may be especially prone to depression this time of ... For some older people, the holidays can generate feelings of ... or health problems, experts note. , To help seniors ... offers the following tips: , Socialize. Ask family and ...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today that ... Company that it will evaluate the,approval of potential anti-arrhythmic ... ongoing review of the Company,s,supplemental new drug application (sNDA)., ... seeking expansion to the,approved product labeling for Ranexa to ...
... Legendary blues artists Bobby,Rush and James "Super Chikan" Johnson ... Blues Marathon and Half-Marathon on Saturday,January 5, 2008. The ... at 200,South Commerce Street, in downtown Jackson. Doors will ... on stage at 8:00 p.m., and the Bobby Rush,Revue ...
... Ala., Dec. 7 BioHorizons Implant Systems,Inc. ... to a,state-of-the- art, 44,000 square foot facility. ... houses all administrative services, a newly,formed manufacturing ... will include machining, surface treatment and packaging ...
Cached Medicine News:Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3Health News:Study shows new strategy for developing antidepressants 2Health News:Study shows new strategy for developing antidepressants 3Health News:How to Spot, and Beat, the Holiday Blues 2Health News:FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R) 2Health News:FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R) 3Health News:BioHorizons Expands to New 44,000 Square Foot Facility 2
... acuity system allows you access to the ... The system includes 10 different optotypes, crowding ... animated characters. Random character sequencing eliminates memorization. ... single line and multiple line selection capability. ...
... Light Probes provide the surgeon with an ... interface to be easily visualized through the ... effect and light scatter technique, the surgeon ... deposits, flap edge folds, corneal flap striae ...
... visual acuity system allows you access to ... II. The system includes 10 different optotypes, ... and animated characters. Random character sequencing eliminates ... letter, single line and multiple line selection ...
... to 64 channel sleep diagnostic collection software. ... 64 channel sleep diagnostic collection software offers ... recording or post recording. The scoring displays ... sleep events including current number of events, ...
Medicine Products: